These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 32014739)
1. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739 [TBL] [Abstract][Full Text] [Related]
2. Biomimetic Nanovaccines Potentiating Dendritic Cell Internalization via CXCR4-Mediated Macropinocytosis. Yang C; Zhang F; Chen F; Chang Z; Zhao Y; Shao D; Sun W; Dong WF; Wang Z Adv Healthc Mater; 2023 Feb; 12(5):e2202064. PubMed ID: 36416257 [TBL] [Abstract][Full Text] [Related]
3. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy. Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883 [TBL] [Abstract][Full Text] [Related]
4. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897 [TBL] [Abstract][Full Text] [Related]
5. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase. Guan X; Chen J; Hu Y; Lin L; Sun P; Tian H; Chen X Biomaterials; 2018 Jul; 171():198-206. PubMed ID: 29698869 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy. Zheng J; Wang M; Pang L; Wang S; Kong Y; Zhu X; Zhou X; Wang X; Chen C; Ning H; Zhao W; Zhai W; Qi Y; Wu Y; Gao Y J Control Release; 2024 Sep; 373():568-582. PubMed ID: 39067792 [TBL] [Abstract][Full Text] [Related]
7. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses. Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy. Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314 [TBL] [Abstract][Full Text] [Related]
9. Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine. Yang C; He Y; Chen F; Zhang F; Shao D; Wang Z Small; 2023 Apr; 19(14):e2207029. PubMed ID: 36703529 [TBL] [Abstract][Full Text] [Related]
10. Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy. Li T; Chen G; Lin L; Li B; Wang X; Chen Y; Huang W; Cai M; Xiao Z; Shuai X; Zhu K Biomaterials; 2024 Sep; 309():122626. PubMed ID: 38795524 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy. Shi C; Jian C; Wang L; Gao C; Yang T; Fu Z; Wu T J Nanobiotechnology; 2023 Sep; 21(1):347. PubMed ID: 37752555 [TBL] [Abstract][Full Text] [Related]
12. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy. Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733 [TBL] [Abstract][Full Text] [Related]
13. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response. Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734 [TBL] [Abstract][Full Text] [Related]
14. Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy. Li Q; Teng Z; Tao J; Shi W; Yang G; Zhang Y; Su X; Chen L; Xiu W; Yuwen L; Dong H; Mou Y Small; 2022 Aug; 18(32):e2201108. PubMed ID: 35734820 [TBL] [Abstract][Full Text] [Related]
15. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response. Song C; Noh YW; Lim YT Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289 [TBL] [Abstract][Full Text] [Related]
16. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens. Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834 [TBL] [Abstract][Full Text] [Related]
17. Leveraging Senescent Cancer Cell Membrane to Potentiate Cancer Immunotherapy Through Biomimetic Nanovaccine. Yang C; Chen Y; Liu J; Zhang W; He Y; Chen F; Xie X; Tang J; Guan S; Shao D; Wang Z; Wang L Adv Sci (Weinh); 2024 Aug; 11(30):e2400630. PubMed ID: 38867377 [TBL] [Abstract][Full Text] [Related]
18. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination. Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
20. Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy. Xiang J; Xu L; Gong H; Zhu W; Wang C; Xu J; Feng L; Cheng L; Peng R; Liu Z ACS Nano; 2015 Jun; 9(6):6401-11. PubMed ID: 26028363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]